(E)-but-2-enedioic acid;N-[2-hydroxy-5-[1-hydroxy-2-[1-(4-methoxyphenyl)propan-2-ylamino]ethyl]phenyl]formamide;dihydrate
データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます
87833-61-2COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1.COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1.O.O.O=C(O)/C=C/C(=O)ORATSWNOMCHFQGJ-XODSYJLDSA-NSee also: Formoterol Fumarate (annotation moved to).
87833-61-2CHEMBL2133469FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
This chemical does not meet GHS hazard criteria for 16.7% (1 of 6) of reports.
Danger
H302+H332 (16.7%): Harmful if swallowed or if inhaled [Warning Acute toxicity, oral; acute toxicity, inhalation]
P203, P260, P261, P264, P270, P271, P273, P280, P284, P301+P317, P304+P340, P308+P316, P316, P317, P318, P319, P320, P321, P330, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 6 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
FORMOTEROL FUMARATE DIHYDRATE
Adrenergic beta2-Agonists [MoA]; beta2-Adrenergic Agonist [EPC]